江西富祥药业股份有限公司 2025年第三季度报告披露提示性公告

Core Viewpoint - Jiangxi Fuxiang Pharmaceutical Co., Ltd. will disclose its Q3 2025 report on October 28, 2025, emphasizing the commitment to accurate and complete information disclosure [1][2]. Group 1 - The company assures that the content of the information disclosure is true, accurate, and complete, with no false records or misleading statements [1]. - The Q3 2025 report will be available on the designated website of the China Securities Regulatory Commission [1].